Trial Profile
Phase I/IIa multiple escalating-dose trial of TX-RAD [T cell therapy; TxCell] in patients with rheumatoid arthritis.
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 22 Mar 2011
Price :
$35
*
At a glance
- Drugs T cell replacement therapy (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms RATS-1
- 22 Mar 2011 New trial record